Gene Query: API5

Dataset Description Geneva Score
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 62.81
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 40.93
RIG-I and MDA5 fRIP during KSHV lytic reactivation 33.81
LncRNA-GAS5 negative regulation of YAP-target genes expression 33.12
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 31.35
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 28.44
RNAseq of HEK293 cells after Chtop knockdown 26.57
Co-transcriptional loading of RNA export factors shapes the human transcriptome 26.57
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 26.27
Co-regulation of splicing by Rbfox1 and hnRNP M 26.27
Studying the selectivity of a small molecule Synucleozid on transcriptome 24.3
21.98
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 20.82
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 20.1
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 19.64
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 19.13
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 18.07
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 18.02
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 17.88
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 17.09
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 16.74
Human cell line and subcutaneous tumor 16.37
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 16.34
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 15.98
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.71
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 15.34
Genome wide miR-191 target profile determined by RIP and gene expression profiling 15.3
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 15.3
3’ Uridylation Expands miRNA Target Repertoire 15.05
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 14.95
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 14.95
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 14.93
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 14.91
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.84
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 14.83
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 14.81
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 14.66
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 14.56
NRDE2 negatively regulates nuclear exosome functions 14.53
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 14.44
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 14.36
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 13.96
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 13.75
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 13.75
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 13.61
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 13.61
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 13.28
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 13.24
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 13.22
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.99
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.99
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.98
Regulation of highly expressed hCINAP on translatome 12.98
Survival of pancreatic cancer cells lacking KRAS function 12.95
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 12.91
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 12.91
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 12.9
Global Mapping of Human RNA-RNA Interactions 12.88
The interplay between SOX4 and SMAD3 in the context of breast cancer 12.75
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 12.12
TT-Seq captures the human transient transcriptome 12.1
RNA-seq melanoma 11.8
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 11.76
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 11.69
RNA-seq of naive and primed ES cells 11.62
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 11.54
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 11.54
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 11.44
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 11.41
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 11.37
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.32
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 11.29
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 11.29
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 11.27
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 11.27
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 11.27
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 11.11
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 11.06
K562 polyA RNA-Seq 11.05
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 10.98
Genes significantly down or Up-regulated upon RNF219 knockdown 10.98
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 10.94
A Unique Epigenomic Landscape Defines Human Erythropoiesis 10.94
Molecular Criteria for Defining the Naive Human Pluripotent State 10.92
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.81
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.75
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 10.73
hTERT promotes cell adhesion and migration independent of telomerase activity 10.7
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 10.59
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 10.59
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 10.48
Tracing Enhancer Networks using Epigenetic Traits (TENET) 10.48
Profiling of escape kinetics of viruses subjected to RNAi 10.44
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.43
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 10.36
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 10.32
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.27
Identifying the molecular mode of action of itraconazole in colorectal cancer 10.18
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 10.17
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 10.16
Zika infected neural stem cells 10.12
Transcriptome analysis of Zika infected neural stem cells 10.12
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 10.1
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 10.02
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 9.97
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 9.94
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 9.94
HEK293 Heat-shock experiment 9.92
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.83
Disruption of the exocyst induces podocyte loss and dysfunction 9.83
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 9.62
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.6
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 9.51
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 9.51
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 9.4
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 9.4
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 9.36
RNA-Seq with and without RNase treatment in PCa cell lines 9.32
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 9.25
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 9.24
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 9.2
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.12
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 9.1
MYC dependent mRNA translation shapes gene expression and cell biology 9.03
The comparison of high-throughput single-cell RNA-seq methods 8.99
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 8.95
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.94
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.93
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 8.9
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 8.8
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 8.72
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 8.7
MEIS1 regulates hematopoiesis in hPSCs 8.63
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 8.55
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.54
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.54
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 8.5
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 8.5
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 8.49
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 8.47
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 8.47
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 8.45
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 8.41
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 8.35
Genome-wide discovery of human splicing branchpoints [RNAse] 8.24
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 8.21
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 8.21
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 8.2
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 8.19
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 8.19
Unique features and clinical importance of acute alloreactive immune responses 8.18
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 8.16
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 8.13
METTL3 promotes translation in human cancer cells 8.08
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 8.01
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 7.99
Differentially expressed vascular development genes for iPSC-ECs from CDI 7.99
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 7.98
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 7.97
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 7.96
Reassessment of Exosome Composition 7.96
Differetially expressed genes after hTR overexpression in U2OS cells 7.92
Effect of FGF13 depletion on the H460 cell line 7.91
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 7.91
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 7.85
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.83
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.83
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 7.8
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 7.8
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 7.78
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 7.78
Transcriptomic analysis of the HOTAIR-regulated genes 7.74
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.71
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 7.71
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 7.71
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.71
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.71
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 7.69
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 7.66
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 7.63
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 7.61
RNAseq Analysis in glioblastoma cells treated with Mepazine 7.6
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 7.59
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 7.51
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 7.51
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 7.46
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 7.43
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 7.38
RNA-Seq of PRMT1 overexpression ECA109 cells 7.36
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 7.36
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 7.35
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 7.35
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.33
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 7.28
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 7.24
RNA sequencing of primary human platelets and in vitro cell lines 7.23
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 7.15
Mapping interactions for the TNIP2 hub protein 7.12
The Genetic Landscape of Diamond-Blackfan Anemia 7.04
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 7.04
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 7.02
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 6.91
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 6.87
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 6.85
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 6.85
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.8
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 6.78
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 6.77
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 6.76
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 6.71
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 6.68
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 6.67
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 6.67
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 6.63
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.63
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.63
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.61
Sensing self and nonself circular RNAs 6.6
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 6.58
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.56
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.56
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 6.55
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 6.54
Exploring the RNA landscape of endothelial exosomes 6.47
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 6.42
UV_24h_GRO-Seq 6.42
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 6.38
Determination of tRNA aminoacylation levels by high throughput sequencing 6.34
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 6.29
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 6.28
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 6.27
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 6.27
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.27
Transcriptome analysis upon C6orf203 silencing 6.27
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.26
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 6.25
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 6.24
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.23
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 6.19
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 6.18
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 6.09
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 6.05
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 6.03
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 6.01
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 5.99
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.95
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.95
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 5.89
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 5.89
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 5.87
RNA-sequencing in irradiated and normal A549 cells. 5.84
The DPYSL2 gene connects mTOR and schizophrenia 5.81
Solid phase chemistry to covalently and reversibly capture thiolated RNA 5.79
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 5.78
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 5.78
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 5.76
Comparative Analysis of Cas9 Activators Across Multiple Species 5.74
Human Treg NaCl stimulation 5.7
Global response to chemotherapy-induced apoptosis 5.69
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 5.63
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 5.63
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.62
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 5.62
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 5.5
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.48
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 5.43
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 5.38
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 5.37
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.36
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.33
Human HAP1 cells before and after nutrient deprivation 5.3
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.3
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 5.26
METTL3 and WTAP 5.25
Effect of ILF3 on translation during homeostasis and the antiviral response 5.19
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.18
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.18
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 5.12
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.11
In vitro modeling of human germ cell development using pluripotent stem cells 5.11
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 5.1
Exogenous rescue of KLHL9 in SF210 cell line 5.1
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 5.08
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 5.07
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.92
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 4.91
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.88
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 4.87
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 4.86
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.76
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 4.61
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.6
RNAseq in Alzheimer's Disease patients 4.52
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.51
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.51
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 4.51
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 4.46
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.43
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.43
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 4.41
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.4
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.4
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.4
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 4.37
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 4.37
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.32
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 4.26
Systematic discovery of endogenous human ribonucleoprotein complexes 4.18
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.17
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.14
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 4.12
The transcriptome effect of overexpressing EZH2 in MCF7 4.05
RNA-seq of RKO cells with cTAZ KO or putback 4.03
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.02
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.97
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 3.84
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 3.83
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 3.74
RNA-seq of Single-Cell Genotyping of Transcriptomes 3.72
Single-Cell Genotyping of Transcriptomes 3.72
miR-93 Targets in Human Endothelial Cells 3.71
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.66
The cohesin release factor WAPL restricts chromatin loop extension. 3.66
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 3.54
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.46
Noncoding regions are the main source of targetable tumor-specific antigens 3.44
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 3.4
An optimization system for isolating and sequencing of single human colon cancer cells 3.4
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.39
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.38
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.36
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.34
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.34
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.34
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 3.34
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 3.34
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.32
MicroRNA targetome analysis during HCMV infection 3.32
Activity-dependent transcriptional changes in human neurons 3.3
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 3.28
Interaction between mitoNEET and NAF-1 in cancer cells 3.22
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 3.21
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 3.21
CDK12 mediated transcriptional regulation in U2OS cells 3.21
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 3.18
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.17
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.17
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.17
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 3.15
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.12
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 3.04
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.04
Gene expression changes due to PARP knockdown in human cells 3.0
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.95
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.95
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.93
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 2.87
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.81
Aneuploidy-induced cellular stresses limit autophagic degradation. 2.76
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.68
Regulatory network controlling tumor-promoting inflammation in human cancers 2.67
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.67
Exploring ILF2 regulatory genes by next-generation sequencing 2.64
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 2.63
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.56
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.54
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.38
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.38
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.31
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.31
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.31
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 2.29
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 2.27
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.25
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.24
Lipid degradation promotes prostate cancer cell survival 2.22
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.2
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.18
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 2.13
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 2.13
Transcriptome of U251 cells overexpression complement component 7 2.04
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 2.04
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.01
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.99
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.99
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.98
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 1.91
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.91
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.9
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.89
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.89
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.88
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.88
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.84
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.82
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.82
Mitochondrial dsRNA triggers antiviral signalling in humans 1.81
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 1.79
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.78
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.78
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 1.78
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.76
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.74
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.74
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 1.71
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.7
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.7
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 1.7
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.68
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.68
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.6
Copper Regulation of HIF-1 Transcription Activity 1.6
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.58
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.55
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.48
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 1.45
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.44
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 1.44
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.42
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.42
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.37
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.36
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.33
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.3
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.3
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.3
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.3
Transposon-based construction of strand-specific RNA-seq libraries 1.3
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.27
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.27
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 1.21
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.2
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.14
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 1.13
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.09
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.09
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.05
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.05
Expression charcaterization of an internal protocol developed to differentiate RPE cells 1.05
RNA-seq of IL-4 stimulated human keratinocytes 1.05
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.03
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.0
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.97
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.95
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.89
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.87
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 0.86
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.82
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.78
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.78
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.77
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.77
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 0.76
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.66
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 0.66
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.63
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 0.61
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 0.58
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 0.57
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 0.49
TOP2B disturbed the quality of human oocytes with advanced maternal age 0.49
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 0.47
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 0.44
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.43
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.42
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.4
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.4
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.39
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.39
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.38
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.37
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 0.37
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.34
Transcriptional landscape changes during human embryonic stem cell derivation 0.33
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.32
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.3
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.3
Human Treg IL-12 stimulation 0.27
Myc activation coordinates gene transcription and protein translation responses 0.25
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 0.23
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 0.23
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.2
Loss of CREBBP results in gene expression repression in lymphoma cells 0.19
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.19
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.19
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.19
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.19
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.19
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.17
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.15
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.13
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.13
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.1
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.1
Modulation of nonsense-mediated decay by rapamycin 0.09
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.04
An siRNA screen identifies CHD4 as a target for epigenetic therapy 0.03
Gene expression alterations of pancreatic intraepithlial neoplasia 0.01
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.0
Dermal endothelial cells of type 2 diabetic patients 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation